| scholarly article | Q13442814 |
| P2093 | author name string | H Alex Brown | |
| Stephen B Milne | |||
| Heidi E Hamm | |||
| Anita M Preininger | |||
| Michael Holinstat | |||
| W James Hudson | |||
| P2860 | cites work | Biphasic kinetics of activation and signaling for PAR1 and PAR4 thrombin receptors in platelets | Q73811661 |
| Protease-activated receptors differentially regulate human platelet activation through a phosphatidic acid-dependent pathway | Q79411445 | ||
| PAR1, but not PAR4, activates human platelets through a Gi/o/phosphoinositide-3 kinase signaling axis | Q79782511 | ||
| Identification of a unique co-operative phosphoinositide 3-kinase signaling mechanism regulating integrin alpha IIb beta 3 adhesive function in platelets | Q80730894 | ||
| Analysis of intact phosphoinositides in biological samples | Q83189880 | ||
| Atherosclerosis — An Inflammatory Disease | Q26776972 | ||
| CalDAG-GEFI integrates signaling for platelet aggregation and thrombus formation | Q28118463 | ||
| The stratification of platelet reactivity and activation in patients with stable coronary artery disease on aspirin therapy | Q28167699 | ||
| Regulation of eukaryotic phosphatidylinositol-specific phospholipase C and phospholipase D | Q28245266 | ||
| Direct thrombin inhibitors | Q28271181 | ||
| PI 3-kinase p110beta: a new target for antithrombotic therapy | Q28588127 | ||
| A randomised, blinded, trial of clopidogrel versus aspirin in patients at risk of ischaemic events (CAPRIE). CAPRIE Steering Committee | Q29620666 | ||
| Rap1b is required for normal platelet function and hemostasis in mice | Q33778323 | ||
| Thrombin stimulation of platelets causes an increase in phosphatidylinositol 5-phosphate revealed by mass assay | Q33905722 | ||
| Thrombin and platelet activation | Q34229835 | ||
| Biphasic activation of PKBalpha/Akt in platelets. Evidence for stimulation both by phosphatidylinositol 3,4-bisphosphate, produced via a novel pathway, and by phosphatidylinositol 3,4,5-trisphosphate | Q34466007 | ||
| PAR4, but not PAR1, signals human platelet aggregation via Ca2+ mobilization and synergistic P2Y12 receptor activation | Q34560212 | ||
| Platelets in atherothrombosis | Q34986345 | ||
| Ischemic heart disease and platelet aggregation. The Caerphilly Collaborative Heart Disease Study | Q35009072 | ||
| Defects in secretion, aggregation, and thrombus formation in platelets from mice lacking Akt2 | Q35632195 | ||
| The pathogenesis of coronary artery disease and the acute coronary syndromes (1). | Q36728740 | ||
| CalDAG-GEFI and protein kinase C represent alternative pathways leading to activation of integrin alphaIIbbeta3 in platelets | Q36843696 | ||
| Kinetic analysis of a mammalian phospholipase D: allosteric modulation by monomeric GTPases, protein kinase C, and polyphosphoinositides | Q37239318 | ||
| Sequential regulation of the small GTPase Rap1 in human platelets | Q39450674 | ||
| Identification of N10-substituted phenoxazines as potent and specific inhibitors of Akt signaling | Q40398965 | ||
| A targeted mass spectrometric analysis of phosphatidylinositol phosphate species | Q40421655 | ||
| ADP-ribosylation factor, a small GTP-dependent regulatory protein, stimulates phospholipase D activity | Q41508317 | ||
| Lipidomics: an analysis of cellular lipids by ESI-MS. | Q42498340 | ||
| Phosphatidic acid regulates the affinity of the murine phosphatidylinositol 4-phosphate 5-kinase-Ibeta for phosphatidylinositol-4-phosphate | Q42798203 | ||
| Measurement of GTP-bound Ras-like GTPases by activation-specific probes | Q43635844 | ||
| Differential regulation of Rho and Rac through heterotrimeric G-proteins and cyclic nucleotides. | Q43740234 | ||
| Inhibition of platelet glycoprotein IIb/IIIa with eptifibatide in patients with acute coronary syndromes | Q44272454 | ||
| Akt Activation in Platelets Depends on Gi Signaling Pathways | Q44659684 | ||
| Blockade of PI3Kgamma suppresses joint inflammation and damage in mouse models of rheumatoid arthritis. | Q46674143 | ||
| Rho and Rho-kinase Mediate Thrombin-induced Phosphatidylinositol 4-Phosphate 5-Kinase Trafficking in Platelets | Q57372258 | ||
| Interaction of pp60c-src, phospholipase C, inositol-lipid, and diacyglycerol kinases with the cytoskeletons of thrombin-stimulated platelets | Q67697815 | ||
| Thrombin stimulates the production of a novel polyphosphoinositide in human platelets | Q68449002 | ||
| Modulation of rat brain cytosolic phosphatidate phosphohydrolase: effect of cationic amphiphilic drugs and divalent cations | Q70173369 | ||
| Thrombin receptor ligation and activated rac uncap actin filament barbed ends through phosphoinositide synthesis in permeabilized human platelets | Q72033892 | ||
| Novel function of phosphatidylinositol 4,5-bisphosphate as a cofactor for brain membrane phospholipase D | Q72135980 | ||
| P433 | issue | 2 | |
| P304 | page(s) | 301-313 | |
| P577 | publication date | 2009-05-29 | |
| P1433 | published in | Molecular Pharmacology | Q1943386 |
| P1476 | title | Irreversible platelet activation requires protease-activated receptor 1-mediated signaling to phosphatidylinositol phosphates | |
| P478 | volume | 76 |
| Q37721192 | Akt signaling in platelets and thrombosis |
| Q37671483 | Dichotomous effects of exposure to bivalirudin in patients undergoing percutaneous coronary intervention on protease-activated receptor-mediated platelet activation |
| Q41884542 | Impaired alpha(IIb)beta(3) integrin activation and shear-dependent thrombus formation in mice lacking phospholipase D1. |
| Q42082080 | Impaired feedback regulation of the receptor activity and the myofilament Ca2+ sensitivity contributes to increased vascular reactiveness after subarachnoid hemorrhage |
| Q36387226 | Investigations of human platelet-type 12-lipoxygenase: role of lipoxygenase products in platelet activation |
| Q51615143 | Mathematical model of PAR1-mediated activation of human platelets. |
| Q46681431 | Platelet Lipidomic Profiling: Novel Insight into Cytosolic Phospholipase A2α Activity and Its Role in Human Platelet Activation |
| Q89169483 | Platelet Signaling and Disease: Targeted Therapy for Thrombosis and Other Related Diseases |
| Q37807924 | Platelet receptor signaling in thrombus formation |
| Q90672234 | Protease-Activated Receptor 1 as Therapeutic Target in Breast, Lung, and Ovarian Cancer: Pepducin Approach |
| Q36717080 | Protease-activated receptor (PAR) 1 and PAR4 differentially regulate factor V expression from human platelets |
| Q34560219 | Protease-activated receptor signaling in platelets activates cytosolic phospholipase A2α differently for cyclooxygenase-1 and 12-lipoxygenase catalysis |
| Q35785016 | Role for the guanine nucleotide exchange factor phosphatidylinositol-3,4,5-trisphosphate-dependent rac exchanger 1 in platelet secretion and aggregation |
| Q34342288 | The roles and mechanisms of PAR4 and P2Y12/phosphatidylinositol 3‐kinase pathway in maintaining thrombin‐induced platelet aggregation |
Search more.